5 Severe Magnesium Abnormalities
Recognize severe magnesium deficiency and toxicity, their cardiac and neuromuscular effects, and the urgent assessment and treatment priorities described here.
Urgent assessment and monitoring
Suspected severe magnesium disorders require urgent clinical assessment, monitoring, and treatment under local protocols. Assessment of a serious magnesium abnormality should include renal function, ECG, magnesium, potassium, and calcium.
can cause tremor, tetany, seizures, prolonged QT, and life-threatening ventricular arrhythmias. Symptomatic or unstable patients generally need monitored intravenous magnesium.
Torsades and QT prolongation
A markedly prolonged QT interval with in a patient with low serum magnesium indicates a dangerous ventricular arrhythmia. Give IV urgently with continuous ECG monitoring and follow the emergency arrhythmia protocol. A commonly cited adult dose for torsades is 1–2 g IV. If the rhythm becomes pulseless or unstable, defibrillation and standard resuscitation measures are needed.
Assess and address potassium and calcium abnormalities, review QT-prolonging medicines, and treat the cause of magnesium loss. Hypokalemia and hypocalcemia can accompany magnesium deficiency, and low potassium may be difficult to correct until magnesium is replenished.
Severe symptomatic deficiency
For with tetany or seizure, give intravenously as an emergency intervention. In an unstable adult, a commonly referenced initial approach is 1–2 g over about 15 minutes. Dosing and repeat treatment must be guided by clinical response, renal function, and local protocol.
Use continuous cardiac monitoring and reassess neurologic status, blood pressure, renal function, magnesium, potassium, and calcium. Severe deficiency can cause seizures, neuromuscular irritability, and dangerous arrhythmias. Use additional caution and closer monitoring when renal function is impaired.
Magnesium deficiency and persistent hypokalemia
Magnesium deficiency can promote renal potassium loss, making hypokalemia refractory to potassium replacement alone. When potassium remains low despite replacement and magnesium is low, replete magnesium as clinically indicated and continue to monitor and replace potassium. Assess renal function and other contributing causes.
Severe
Severe can cause hyporeflexia, weakness, hypotension, respiratory depression, bradycardia, PR prolongation, QRS widening, heart block, and cardiac arrest. Bradycardia with PR prolongation and QRS widening in a patient with kidney failure and high serum magnesium suggests magnesium-related cardiac conduction depression.
Stop magnesium sources and support airway, breathing, and circulation. Monitor the ECG and vital signs. For severe toxicity or life-threatening manifestations, can temporarily counteract magnesium’s cardiac and neuromuscular effects. Promote magnesium removal; a loop diuretic may be considered when kidney function and volume status allow.
Consider in severe or refractory toxicity, particularly with significant renal impairment. Do not delay emergency supportive care while arranging definitive treatment.
Recognizing magnesium emergencies
Increasing weakness and sleepiness, loss of deep-tendon reflexes, shallow breathing, and hypotension during magnesium therapy should raise suspicion of severe and magnesium toxicity. Stop magnesium administration, urgently assess and support airway and breathing, provide circulatory support, and begin continuous cardiac and respiratory monitoring. Give IV calcium for severe manifestations according to emergency protocol, and assess the need for dialysis, especially if renal clearance is impaired.
The contrasting ECG patterns can help distinguish the abnormalities:
Low magnesium: Markedly prolonged QT with risk of and ventricular arrhythmia.
High magnesium: Bradycardia with PR prolongation and QRS widening; worsening toxicity can cause high-grade heart block, respiratory depression, and cardiac arrest.